<DOC>
	<DOC>NCT01191125</DOC>
	<brief_summary>To evaluate the effect of an experimental oral nutritional supplement containing AN777 compared to another oral nutritional supplement in a malnourished, elderly population.</brief_summary>
	<brief_title>Evaluation of an Oral Nutritional Supplement Containing AN777</brief_title>
	<detailed_description />
	<mesh_term>Malnutrition</mesh_term>
	<mesh_term>Sarcopenia</mesh_term>
	<criteria>Subject (male or female) is &gt; or equal to 65 and &lt; or equal to 90 years of age Subject is ambulatory Subject has a Subjective Global Assessment of B or C Subject has gait speed &lt;0.8 m/s AND/OR low handgrip strength Subject has Class 1 or Class 2 sarcopenia Subject agrees to refrain from starting a resistance exercise program Subject has type 1 or type 2 diabetes Subject has inflammatory disease with elevated high sensitivity Creactive protein Subject has renal function impairment Subject reports gastrointestinal disorder (severe chronic diarrhea, nausea, vomiting) that would preclude ingestion of the study product; an obstruction of the gastrointestinal tract, inflammatory bowel disease; short bowel syndrome or other major gastrointestinal disease Subject reports of current active malignant disease or other significant medical diagnoses. Subject reports a history of allergy to any of the ingredients in the study products Subject reports currently taking medications/dietary supplements/substances that could profoundly modulate metabolism or weight.</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>